Prithvi Raj

Hi. This is Prithvi Raj from Unifi Capital. Let me begin with the domestic hospital business first. I think the EBITDA growth of 40% despite not adding any beds in the last 7 to 8 years is quite remarkable. In this context, my first question is with respect to the revenue growth.

That is clear. Just on margins front, you made a point of the 24% EBITDA margin. See, if we compare your ARPOB with other competitors, it is significantly lower. However, your margins are largely on par with the competitors. And as you have taken several initiatives on efficiency, etcetera., but do you think is there a further scope for hospitals' margins to go up or it should stabilize at these levels?

One final question on domestic business. If you look at the insurance space, I think the losses spiked significantly during the quarter. Just trying to understand, what has changed so much in one quarter that, the losses spiked up in a big way, and should we expect these losses to sustain for the next few quarters or is it more of a one-off quarter? So what explains this domestic insurance losses?